Cite
Pfennigsdorf S, Ramez O, von Kistowski G, et al. Multicenter, prospective, open-label, observational study of bimatoprost 0.01% in patients with primary open-angle glaucoma or ocular hypertension. Clin Ophthalmol. 2012;6:739-46doi: 10.2147/OPTH.S31330.
Pfennigsdorf, S., Ramez, O., von Kistowski, G., Mäder, B., Eschstruth, P., Froböse, M., Thelen, U., Spraul, C., Schnober, D., Cooper, H., & Laube, T. (2012). Multicenter, prospective, open-label, observational study of bimatoprost 0.01% in patients with primary open-angle glaucoma or ocular hypertension. Clinical ophthalmology (Auckland, N.Z.), 6739-46. https://doi.org/10.2147/OPTH.S31330
Pfennigsdorf, Stefan, et al. "Multicenter, prospective, open-label, observational study of bimatoprost 0.01% in patients with primary open-angle glaucoma or ocular hypertension." Clinical ophthalmology (Auckland, N.Z.) vol. 6 (2012): 739-46. doi: https://doi.org/10.2147/OPTH.S31330
Pfennigsdorf S, Ramez O, von Kistowski G, Mäder B, Eschstruth P, Froböse M, Thelen U, Spraul C, Schnober D, Cooper H, Laube T. Multicenter, prospective, open-label, observational study of bimatoprost 0.01% in patients with primary open-angle glaucoma or ocular hypertension. Clin Ophthalmol. 2012;6:739-46. doi: 10.2147/OPTH.S31330. Epub 2012 May 11. PMID: 22654501; PMCID: PMC3363312.
Copy
Download .nbib